AstraZeneca's ($AZN) MedImmune has licensed a toll-like receptor (TLR) agonist from 3M ($MMM), in the hopes that intratumoral injection of the candidate will allow ...
Add Yahoo as a preferred source to see more of our stories on Google. Of course, it's the real estate left in the divorce wake that really concerns us. Doesn't anybody stay together for the condos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results